Treatment for Endogenous Cushing's Syndrome

Clinical trial NCT01838551 · COMPLETED

Trial details

NCT number: NCT01838551
Sponsor: Cortendo AB
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Endogenous Cushing's Syndrome

Start date: 2014-08-01
Primary completion: 2018-04-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.